JAMP-Pregabalin: One lot recalled as some bottles may contain 150 mg…
JAMP-Pregabalin: One lot recalled as some bottles may contain 150 mg capsules
- Published
- 5 May 2025
- Agency
- Health Canada
- Country
- Canada
The hazard
Product safety
Classification: Type I
What to do
Check your medication bottle to ensure it only contains 50 mg capsules. The 50 mg capsule is white with “PG” and “50” printed on it in black ink. The 150 mg capsule is white with “PG” and “150” printed on it in black ink. If it contains any 150 mg capsules, or if you are unsure, return it to your pharmacy immediately. Your pharmacist will check the capsules and provide you with a replacement, if needed. If you are unable to return your capsules to the pharmacy right away, talk to your pharmacist or doctor for further guidance. Seek immediate medical attention if you are experiencing symptoms of an overdose (e.g., confusion, agitation, restlessness and seizures). Do not stop taking pregabalin without first speaking to your doctor, as stopping abruptly may result in withdrawal symptoms. If you have questions about this recall, contact JAMP Pharma Corp. by calling 1-866-399-9091, extension 501, or by emailing [email protected]. Report any health product-related side effects or complaints to Health Canada.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Source: Health Canada, published 5 May 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.